Millipore Corporation has completed the acquisition of over 90% of the shares of NovAseptic AB from the company's majority shareholders. Millipore is in the process of acquiring the remaining shares from the minority shareholders.
NovAseptic, based in Gothenburg, Sweden, provides a range of innovative solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. NovAseptic's products include disposable sampling system (NovaSeptum) and a range of high-performance mixers, valves, and connectors.
Martin Madaus, Millipore's chairman, CEO and president, noted: "NovAseptic brings innovative and differentiated products that our biotech and pharmaceutical customers value highly for manufacturing biologics and for monitoring bio-manufacturing processes. There is a great fit strategically and tactically, and we've added exceptional technology and talent to Millipore."